Serevent - News Articles

Dendritic Cells in Chronic Obstructive Pulmonary Disease - Health - redOrbit
Jun 3, 2008
RedOrbit, TX -
Dendritic cells (DCs) are professional antigen-presenting cells responsible for immune homeostasis. In the lung's responses to tissue damage or infection, they initiate and orchestrate innate and adaptive immunity. There are immature and mature states and at least three phenotypic ...
Biomarkers for Chronic Obstructive Pulmonary Disease - Health - redOrbit
Jun 3, 2008
RedOrbit, TX -
By Dahl, Morten Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation, chronic lung inflammation, and extrapul-monary systemic effects. In chronic lung inflammation, elevated protease and oxidant levels are believed to contribute to degradation of lung tissue ...
Use of Inhaled Corticosteroids to Treat Stable COPD - Health - redOrbit
Jun 3, 2008
RedOrbit, TX -
By Cayley, William E Jr Clinical Scenario A 60-year-old patient with a 40 pack-year smoking history requests ?something else? to treat his chronic cough and dyspnea from chronic obstructive pulmonary disease (COPD). He is already using an albuterol/ipratropium (Combivent) inhaler as needed. ...
Inhaled Corticosteroids Might Not Protect Against Lung Cancer/From the Authors - Health - redOrbit
Jun 3, 2008
RedOrbit, TX -
To the Editor: We read with interest the cohort study by Dr. Parimon and colleagues (1), which suggested a reduced risk of lung cancer among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:712-719. 2. The Alpha-Tocopherol, Beta Carotene ...
Neuromed Names Sean Cunliffe Chief Commercial Officer
Apr 29, 2008
Earthtimes (press release), UK -
CONSHOHOCKEN, PA and VANCOUVER, BC, April 29 -- Neuromed Pharmaceuticals, a biopharmaceutical company developing new and improved chronic pain drugs, today announced the promotion of Sean Cunliffe to Chief Commercial Officer. Mr. Cunliffe will lead all pre- and post-approval ...
Drug distribution restricted as manufacturers attempt to guard supply chain - Pharmaceutical Business Review
May 7, 2008
Pharmaceutical Business Review -
GSK stopped filling Greek wholesaler orders for three drugs - Imigran (sumatriptan), Lamictal (lamotrigine) and Serevent (salmeterol) - in 2000, distributing directly to pharmacies and hospitals instead. In 2001, the company reinstated restricted wholesaler distribution. Greek ...
PharmaLive: GSK Statement on US Food and Drug Administration Pediatric Advisory Committee Recommendations Regarding Salmeterol
Nov 29, 2007
PharmaLive.com (press release), PA -
2007 – Untreated and uncontrolled asthma is an urgent public health issue and Serevent ® (salmeterol xinafoate) and Advair ® (fluticasone propionate and ...
The New York Times > Log In
Nov 28, 2007
New York Times, United States -
28 (Reuters) — Federal regulatory advisers on Wednesday recommended strengthening safety warnings on GlaxoSmithKline’s asthma drug Serevent amid reports of ...
FDA staff: Asthma drug safety review needed in children - MarketWatch
Nov 23, 2007
MarketWatch -
The FDA looked at adverse-safety events associated with Serevent and Advair from March 9, 2006, through April 9, 2007, as part of a routine safety review of drugs approved for use in children. The agency's pediatric-advisory committee is scheduled to discuss the safety review of Serevent, ...
Glaxo asthma drug needs kid risk warning: FDA panel| Health| Reuters
Nov 28, 2007
Reuters India, India -
GAITHERSBURG, Maryland (Reuters) - Regulatory advisers on Wednesday recommended strengthening safety warnings on GlaxoSmithKline Plc's asthma drug Serevent ...
Bloomberg.com: U.K. & Ireland
Nov 23, 2007
Bloomberg -
23 (Bloomberg) -- GlaxoSmithKline Plc's asthma drugs Serevent and Advair, the company's biggest-selling medications, may have rare and deadly side effects for children, safetyofficials at the U.S. Food and Drug Administration said. ...
FDA Says Serevent Risk-Benefit Profile for Use in Kids Is Unfavorable
Nov 27, 2007
FDA news (subscription), VA -
The FDA is recommending to the Pediatric Advisory Committee that a thorough risk-benefit analysis for GlaxoSmithKline’s (GSK) asthma treatment Serevent is ...
FDA Advisory Committee Wants Stronger Warning for Serevent
Nov 29, 2007
FDA news (subscription), VA -
The FDA’s Pediatric Advisory Committee recommended that the agency strengthen the boxed warning for GlaxoSmithKline’s (GSK) asthma treatment Serevent to ...
Serevent and Advair May Cause Injury, Death in Children, FDA Report Says
Nov 26, 2007
Newsinferno.com, NY -
Serevent and Advair, top-selling asthma drugs, will take center stage this week, when a Food & Drug Administration (FDA) panel meets to discuss the use of Advair and Serevent in children. According to documents posted on the FDA website last week, nine patients under ...
Serevent Should Have Stronger Warnings About Fatal Side Effects in Children, FDA Panel Says
Nov 29, 2007
Newsinferno.com, NY -
Serevent, a top selling asthma drug, needs stronger safety warnings, a Food & Drug Advisory (FDA) panel said yesterday. The FDA panel’s Serevent ...
FDA panel wants extra warnings on Glaxo asthma drugs Advair, Serevent - Triangle Business Journal:
Nov 29, 2007
Bizjournals.com, NC -
The FDA panel also said the information should be placed on the label of Serevent, another GSK asthma drug with the same active ingredient as Advair. The full FDA is not obligated to follow the recommendations of its panels, though it usually does. ...
SunHerald.com : Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs
Thursday, December 20, 2007
SunHerald.com, MS -
By Pearl Therapeutics, Inc. Pearl Therapeutics, Inc., a biopharmaceutical company developing treatments for major respiratory diseases, today announced the appointment of Colin Reisner, MD, FCCP, FAAAAIto the position of Chief Medical Officer and Executive Vice President ofClinical Development ...
Don't stop asthma meds while pregnant | TimesDaily.com | Times Daily | Florence, AL
Nov 6, 2007
Times Daily (subscription), AL -
proventil) are considered safe. the inhaled long-acting bronchodilators such as salmeterol (serevent) appear to be safe as well. and cromolyn (intal) is ...
OrthoLogic: The Wall Street Analyst Forum Presentation Transcript - Seeking Alpha
Sep 20, 2007
Seeking Alpha, NY -
Pletal for intermediate claudication, peripheral artery disease related indication, Serevent for asthma and Viagra for erectile dysfunction. All of these agents are cell surface mediated, smooth muscle relaxing type agents. And they all require these rather ...
New Asthma Treatment Approach Shows Promise
Sep 24, 2007
About - News & Issues, NY -
Apparently a combination drug (Symbicort SMART) made up of budesonide (brand name: Pulmicort in the US) and salmeterol (brand name: Serevent in the US) was ...

Pages:   1   2   3   4   Next

These articles are related to: Serevent Claim, Serevent Lawsuit, Serevent Law Suit, Serevent Law Firm, Serevent Lawyer, Serevent Attorney, Serevent Side Effects Symptoms, Serevent Trial, Serevent Verdict, Serevent News, Serevent Information, Serevent Recall Lawyers, Serevent Warning, Serevent Class Action, Serevent Prescription Drug, Serevent Medication, Serevent Drugs, Salmeterol Xinafoate Claim, Salmeterol Xinafoate Lawsuit, Salmeterol Xinafoate Law Suit, Salmeterol Xinafoate Law Firm, Salmeterol Xinafoate Lawyer, Salmeterol Xinafoate Attorney, Salmeterol Xinafoate Side Effects Symptoms, Salmeterol Xinafoate Trial, Salmeterol Xinafoate Verdict, Salmeterol Xinafoate News, Salmeterol Xinafoate Information, Salmeterol Xinafoate Recall Lawyers, Salmeterol Xinafoate Warning, Salmeterol Xinafoate Class Action, Salmeterol Xinafoate Prescription Drug, Salmeterol Xinafoate Medication, Salmeterol Xinafoate Drugs

AddThis Social Bookmark Button

 

Need A Serevent Attorney?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury
Click to Ask a Question

Your Friend's Email Address

Your Email Address

Type a Message (optional)


 

Need A Serevent Lawyer?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury
Click to Ask a Question

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Serevent Case - Submit Your Information Below

Do you need legal assistance with your Serevent case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * Unsafe Drugs: Serevent Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.